Home health care - Adjuvant everolimus nonsignificantly improved recurrence-free survival in renal cancer

CHICAGO - In renal cell carcinoma, adjuvant everolimus improved recurrence-free survival after nephrectomy but narrowly missed the benchmark for statistical significance...